News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Philippe Aftimos/LinkedIn
Jun 3, 2025, 18:29

Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC

Philippe Aftimos, Medical Oncologist at the Jules Bordet Institute, shared a post on LinkedIn:

“At the metastatic breast cancer poster session this morning at ASCO25, Elisa Agostinetto presents OS results and ctDNA analyses from the SYNERGY randomized phase 2 academic study sponsored by Institut Jules Bordet.
SYNERGY investigated the combination of oleclumab and durvalumab with chemotherapy in the 1st line setting of metastatic TNBC.”

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Elisa Agostinetto

ASCO ASCO 2025 ASCO25 Breast Cancer cancer Durvalumab Elisa Agostinetto Institut Jules Bordet Jules Bordet Institute metastatic breast cancer oleclumab OncoDaily Oncology Philippe Aftimos SYNERGY trial TNBC
Special Coverage
Blog
Jun 4, 2025, 17:07
Teresa Amaral: The Fantastic Faculty of The ASCO and ESMO Session at ASCO25 Congress
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)
Blog
Jun 4, 2025, 15:56
SIOG Announces Interactive Geriatric Assessment Workshop for SIOG 2025
Blog
Jun 4, 2025, 15:45
Teresa Amaral: Honored to Present Streamlining Clinical Research Project by ESMO, ASCO, and ESMO Industry Strategic Forum
Insight
Jun 4, 2025, 14:21
Princess Adila: Her Royal Highness, Her Human Mission - CancerWorld
Blog
Jun 4, 2025, 13:42
Florez Lab Presented The EQUAL Study at ASCO25